193 related articles for article (PubMed ID: 23326584)
1. A homogeneous, high-throughput assay for phosphatidylinositol 5-phosphate 4-kinase with a novel, rapid substrate preparation.
Davis MI; Sasaki AT; Shen M; Emerling BM; Thorne N; Michael S; Pragani R; Boxer M; Sumita K; Takeuchi K; Auld DS; Li Z; Cantley LC; Simeonov A
PLoS One; 2013; 8(1):e54127. PubMed ID: 23326584
[TBL] [Abstract][Full Text] [Related]
2. Method for Assaying the Lipid Kinase Phosphatidylinositol-5-phosphate 4-kinase α in Quantitative High-Throughput Screening (qHTS) Bioluminescent Format.
Davis MI; Sasaki AT; Simeonov A
Methods Mol Biol; 2016; 1376():1-9. PubMed ID: 26552670
[TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 5-phosphate 4-kinase γ (PI5P4Kγ), a lipid signalling enigma.
Giudici ML; Clarke JH; Irvine RF
Adv Biol Regul; 2016 May; 61():47-50. PubMed ID: 26710750
[TBL] [Abstract][Full Text] [Related]
4. Bioluminescence Methods for Assaying Kinases in Quantitative High-Throughput Screening (qHTS) Format Applied to Yes1 Tyrosine Kinase, Glucokinase, and PI5P4Kα Lipid Kinase.
Davis MI; Auld DS; Inglese J
Methods Mol Biol; 2016; 1360():47-58. PubMed ID: 26501901
[TBL] [Abstract][Full Text] [Related]
5. High-throughput, cell-free, liposome-based approach for assessing in vitro activity of lipid kinases.
Demian DJ; Clugston SL; Foster MM; Rameh L; Sarkes D; Townson SA; Yang L; Zhang M; Charlton ME
J Biomol Screen; 2009 Aug; 14(7):838-44. PubMed ID: 19641220
[TBL] [Abstract][Full Text] [Related]
6. A versatile high-throughput screen for inhibitors of lipid kinase activity: development of an immobilized phospholipid plate assay for phosphoinositide 3-kinase gamma.
Fuchikami K; Togame H; Sagara A; Satoh T; Gantner F; Bacon KB; Reinemer P
J Biomol Screen; 2002 Oct; 7(5):441-50. PubMed ID: 14599360
[TBL] [Abstract][Full Text] [Related]
7. Measuring Activity of Phosphoinositide Lipid Kinases Using a Bioluminescent ADP-Detecting Assay.
Tai AW; Vidugiriene J
Methods Mol Biol; 2016; 1360():75-85. PubMed ID: 26501903
[TBL] [Abstract][Full Text] [Related]
8. A high-throughput, nonisotopic, competitive binding assay for kinases using nonselective inhibitor probes (ED-NSIP).
Vainshtein I; Silveria S; Kaul P; Rouhani R; Eglen RM; Wang J
J Biomol Screen; 2002 Dec; 7(6):507-14. PubMed ID: 14599348
[TBL] [Abstract][Full Text] [Related]
9. Development of a High-Throughput Screening Assay to Identify Inhibitors of the Lipid Kinase PIP5K1C.
Wright BD; Simpson C; Stashko M; Kireev D; Hull-Ryde EA; Zylka MJ; Janzen WP
J Biomol Screen; 2015 Jun; 20(5):655-62. PubMed ID: 25534829
[TBL] [Abstract][Full Text] [Related]
10. Development and application of PI3K assays for novel drug discovery.
Yanamandra M; Mitra S; Giri A
Expert Opin Drug Discov; 2015 Feb; 10(2):171-86. PubMed ID: 25547459
[TBL] [Abstract][Full Text] [Related]
11. A homogeneous and nonisotopic assay for phosphatidylinositol 4-kinases.
Tai AW; Bojjireddy N; Balla T
Anal Biochem; 2011 Oct; 417(1):97-102. PubMed ID: 21704602
[TBL] [Abstract][Full Text] [Related]
12. A high-throughput liposome substrate assay with automated lipid extraction process for PI 3-kinase.
Lingaraj T; Donovan J; Li Z; Li P; Doucette A; Harrison S; Ecsedy JA; Dang L; Zhang W
J Biomol Screen; 2008 Oct; 13(9):906-11. PubMed ID: 18812570
[TBL] [Abstract][Full Text] [Related]
13. Substrate competitive inhibitors of IGF-1 receptor kinase.
Blum G; Gazit A; Levitzki A
Biochemistry; 2000 Dec; 39(51):15705-12. PubMed ID: 11123895
[TBL] [Abstract][Full Text] [Related]
14. A large scale high-throughput screen identifies chemical inhibitors of phosphatidylinositol 4-kinase type II alpha.
Sengupta N; Jović M; Barnaeva E; Kim DW; Hu X; Southall N; Dejmek M; Mejdrova I; Nencka R; Baumlova A; Chalupska D; Boura E; Ferrer M; Marugan J; Balla T
J Lipid Res; 2019 Mar; 60(3):683-693. PubMed ID: 30626625
[TBL] [Abstract][Full Text] [Related]
15. Semi-Automated High-Throughput Substrate Screening Assay for Nucleoside Kinases.
Hellendahl KF; Fehlau M; Hans S; Neubauer P; Kurreck A
Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768989
[TBL] [Abstract][Full Text] [Related]
16. Development of an in vitro screening assay for PIP5K1α lipid kinase and identification of potent inhibitors.
Strätker K; Haidar S; Amesty Á; El-Awaad E; Götz C; Estévez-Braun A; Jose J
FEBS J; 2020 Jul; 287(14):3042-3064. PubMed ID: 31876381
[TBL] [Abstract][Full Text] [Related]
17. Determination of the catalytic activities of mTOR and other members of the phosphoinositide-3-kinase-related kinase family.
Chiang GG; Abraham RT
Methods Mol Biol; 2004; 281():125-41. PubMed ID: 15220525
[TBL] [Abstract][Full Text] [Related]
18. A bioluminogenic HDAC activity assay: validation and screening.
Halley F; Reinshagen J; Ellinger B; Wolf M; Niles AL; Evans NJ; Kirkland TA; Wagner JM; Jung M; Gribbon P; Gul S
J Biomol Screen; 2011 Dec; 16(10):1227-35. PubMed ID: 21832257
[TBL] [Abstract][Full Text] [Related]
19. Multimodal action of KRP203 on phosphoinositide kinases in vitro and in cells.
Ikeda Y; Davis MI; Sumita K; Zheng Y; Kofuji S; Sasaki M; Hirota Y; Pragani R; Shen M; Boxer MB; Takeuchi K; Senda T; Simeonov A; Sasaki AT
Biochem Biophys Res Commun; 2023 Oct; 679():116-121. PubMed ID: 37683456
[TBL] [Abstract][Full Text] [Related]
20. Coordinated activation of the nuclear ubiquitin ligase Cul3-SPOP by the generation of phosphatidylinositol 5-phosphate.
Bunce MW; Boronenkov IV; Anderson RA
J Biol Chem; 2008 Mar; 283(13):8678-86. PubMed ID: 18218622
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
